Amedeo Smart

Free Medical Literature Service



Stem Cell Research

  Free Subscription

Articles published in
    August 2023
  1. TAN XY, Li YT, Li HH, Ma LX, et al
    WNT2-SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer.
    Oncogene. 2023 Aug 26. doi: 10.1038/s41388-023-02816.
    >> Share

    May 2023
  2. JIA Y, Ding X, Zhou L, Zhang L, et al
    Retraction Note: Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Oncogene. 2023 May 30. doi: 10.1038/s41388-023-02726.
    >> Share

    April 2023
  3. SANE S, Srinivasan R, Potts RA, Eikanger M, et al
    UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer.
    Oncogene. 2023 Apr 10. doi: 10.1038/s41388-023-02686.
    >> Share

    March 2023
  4. MA Y, Zhu Y, Shang L, Qiu Y, et al
    LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling.
    Oncogene. 2023 Mar 15. doi: 10.1038/s41388-023-02652.
    >> Share

  5. YENDE AS, Williams EC, Pletcher A, Helfand A, et al
    TRIM28 promotes luminal cell plasticity in a mouse model of prostate cancer.
    Oncogene. 2023 Mar 8. doi: 10.1038/s41388-023-02655.
    >> Share

  6. VORONTSOVA A, Cooper TJ, Haj-Shomaly J, Benguigui M, et al
    Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors.
    Oncogene. 2023;42:771-781.
    >> Share

  7. AN N, Khan S, Imgruet MK, Jueng L, et al
    Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells.
    Oncogene. 2023;42:881-893.
    >> Share

    February 2023
  8. KWON JW, Seok SH, Kim S, An HW, et al
    A synergistic partnership between IL-33/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis.
    Oncogene. 2023;42:501-515.
    >> Share

    January 2023
  9. CHEN F, Gurler SB, Novo D, Selli C, et al
    RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells.
    Oncogene. 2023 Jan 5. doi: 10.1038/s41388-022-02574.
    >> Share

    December 2022
  10. YU T, Zhou F, Tian W, Xu R, et al
    EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.
    Oncogene. 2022 Dec 14. doi: 10.1038/s41388-022-02570.
    >> Share

  11. LI F, Niu M, Qin K, Guo R, et al
    FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance.
    Oncogene. 2022 Dec 2. doi: 10.1038/s41388-022-02559.
    >> Share

  12. SONG YL, Yang MH, Zhang S, Wang H, et al
    A GRIP-1-EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a.
    Oncogene. 2022;41:5223-5237.
    >> Share

    November 2022
  13. SPINA R, Mills I, Ahmad F, Chen C, et al
    DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts.
    Oncogene. 2022 Nov 7. pii: 10.1038/s41388-022-02517.
    >> Share

    July 2022
  14. BALINTH S, Fisher ML, Hwangbo Y, Wu C, et al
    EZH2 regulates a SETDB1/DeltaNp63alpha axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma.
    Oncogene. 2022 Jul 21. pii: 10.1038/s41388-022-02417.
    >> Share

    June 2022
  15. BUSCHHAUS JM, Rajendran S, Humphries BA, Cutter AC, et al
    Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer.
    Oncogene. 2022 Jun 22. pii: 10.1038/s41388-022-02385.
    >> Share

    May 2022
  16. LORENZO-MARTIN LF, Menacho-Marquez M, Fernandez-Parejo N, Rodriguez-Fdez S, et al
    The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function.
    Oncogene. 2022 May 9. pii: 10.1038/s41388-022-02341.
    >> Share

    April 2022
  17. KUDARAVALLI S, den Hollander P, Mani SA
    Role of p38 MAP kinase in cancer stem cells and metastasis.
    Oncogene. 2022 Apr 30. pii: 10.1038/s41388-022-02329.
    >> Share

  18. LANE R, Cilibrasi C, Chen J, Shah K, et al
    PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling.
    Oncogene. 2022 Apr 7. pii: 10.1038/s41388-022-02294.
    >> Share

    March 2022
  19. YANG YS, Jia XZ, Lu QY, Cai SL, et al
    Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells.
    Oncogene. 2022 Mar 29. pii: 10.1038/s41388-022-02278.
    >> Share

  20. SONG H, Wang J, Wang X, Yuan B, et al
    HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation.
    Oncogene. 2022 Mar 22. pii: 10.1038/s41388-022-02271.
    >> Share

  21. LEE WK, Zhu X, Park S, Zhu YJ, et al
    Regulation of cancer stem cell activity by thyroid hormone receptor beta.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02242.
    >> Share

  22. WU WR, Shi XD, Zhang FP, Zhu K, et al
    Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02246.
    >> Share

  23. ZHANG T, Wang Y, Li Q, Lin L, et al
    Mesenchymal stromal cells equipped by IFNalpha empower T cells with potent anti-tumor immunity.
    Oncogene. 2022;41:1866-1881.
    >> Share

    February 2022
  24. TURDO A, Gaggianesi M, Di Franco S, Veschi V, et al
    Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51.
    Oncogene. 2022 Feb 25. pii: 10.1038/s41388-022-02239.
    >> Share

  25. YUAN S, Zhang P, Wen L, Jia S, et al
    Correction: miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma.
    Oncogene. 2022 Feb 4. pii: 10.1038/s41388-022-02188.
    >> Share

    January 2022
  26. ZOU H, Luo J, Guo Y, Liu Y, et al
    RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7.
    Oncogene. 2022 Jan 31. pii: 10.1038/s41388-022-02198.
    >> Share

  27. FU L, Fan J, Maity S, McFadden G, et al
    PD-L1 interacts with Frizzled 6 to activate beta-catenin and form a positive feedback loop to promote cancer stem cell expansion.
    Oncogene. 2022 Jan 17. pii: 10.1038/s41388-021-02144.
    >> Share

  28. CHEN J, Hou SF, Tang FJ, Liu DS, et al
    HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma.
    Oncogene. 2022;41:99-111.
    >> Share

  29. LEON F, Seshacharyulu P, Nimmakayala RK, Chugh S, et al
    Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer.
    Oncogene. 2022;41:57-71.
    >> Share

    November 2021
  30. CHEN Y, Zhao H, Liang W, Jiang E, et al
    Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3/SOX2 axis.
    Oncogene. 2021 Nov 19. pii: 10.1038/s41388-021-02115.
    >> Share

    October 2021
  31. GAO S, Soares F, Wang S, Wong CC, et al
    CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer.
    Oncogene. 2021 Oct 7. pii: 10.1038/s41388-021-01882.
    >> Share

    August 2021
  32. YAN Y, Narayan A, Cho S, Cheng Z, et al
    CRYbetaB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer.
    Oncogene. 2021 Aug 2. pii: 10.1038/s41388-021-01975.
    >> Share

  33. PAL A, Barrett TF, Paolini R, Parikh A, et al
    Partial EMT in head and neck cancer biology: a spectrum instead of a switch.
    Oncogene. 2021;40:5049-5065.
    >> Share

  34. MELOCCHI V, Dama E, Mazzarelli F, Cuttano R, et al
    Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
    Oncogene. 2021;40:4980-4991.
    >> Share

  35. BAUER J, Cuvelier N, Ragab N, Simon-Keller K, et al
    Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.
    Oncogene. 2021;40:4955-4966.
    >> Share

    July 2021
  36. LI Y, Fei H, Lin Q, Liang F, et al
    ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Oncogene. 2021 Jul 1. pii: 10.1038/s41388-021-01913.
    >> Share

    June 2021
  37. ZHANG J, Guan W, Xu X, Wang F, et al
    A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
    Oncogene. 2021 Jun 23. pii: 10.1038/s41388-021-01891.
    >> Share

  38. TRUONG TH, Benner EA, Hagen KM, Temiz NA, et al
    PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER(+) breast cancer.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01871.
    >> Share

  39. NATHANSEN J, Lukiyanchuk V, Hein L, Stolte MI, et al
    Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Oncogene. 2021;40:4214-4228.
    >> Share

    May 2021
  40. LAGER TW, Conner C, Keating CR, Warshaw JN, et al
    Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01821.
    >> Share

    April 2021
  41. HAO T, Zhang C, Wang Z, Buck A, et al
    An aging mouse model of human chronic myeloid leukemia.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01770.
    >> Share

  42. BLOKZIJL-FRANKE S, Ponsioen B, Schulte-Merker S, Herbomel P, et al
    Phosphatidylinositol-3 kinase signaling controls survival and stemness of hematopoietic stem and progenitor cells.
    Oncogene. 2021;40:2741-2755.
    >> Share

    March 2021
  43. FUKASAWA K, Kadota T, Horie T, Tokumura K, et al
    CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
    Oncogene. 2021 Mar 16. pii: 10.1038/s41388-021-01745.
    >> Share

  44. LEE HC, Ou CH, Huang YC, Hou PC, et al
    YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer.
    Oncogene. 2021 Mar 4. pii: 10.1038/s41388-021-01718.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016